Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa fever.

Communications medicine·2024

Same author

Research and product development for Crimean-Congo haemorrhagic fever: priorities for 2024-30.

The Lancet. Infectious diseases·2024

Same author

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses.

Cell host & microbe·2023

Same author

Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters.

Antiviral research·2023

Same author

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses.

Cell host & microbe·2022

Same author

Broadly neutralizing antibodies target the coronavirus fusion peptide.

Science (New York, N.Y.)·2022

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Vaccines for hantaviruses.

Connie Schmaljohn¹

¹United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702, USA. connie.schmaljohn@amedd.army.mil

|October 20, 2009

Summary

This summary is machine-generated.

Hantaviruses, rodent-borne viruses causing severe diseases like HFRS and HPS, are a biodefense concern. Research is ongoing to develop effective hantavirus vaccines for public health protection.

More Related Videos

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Published on: November 22, 2021

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Related Experiment Videos

Last Updated: Jun 19, 2026

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Published on: November 22, 2021

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Area of Science:

Virology
Immunology
Public Health

Background:

Hantaviruses are rodent-borne viruses belonging to the Bunyaviridae family.
Transmission to humans occurs via aerosols from rodent excreta.
Over 20 hantaviruses are recognized, causing Hemorrhagic Fever with Renal Syndrome (HFRS) or Hantavirus Pulmonary Syndrome (HPS).

Purpose of the Study:

To review the significance of hantaviruses in biodefense.
To provide information on vaccine development for HFRS and HPS.

Main Methods:

Literature review of hantavirus research.
Analysis of vaccine development strategies for HFRS and HPS.

Main Results:

Hantaviruses are classified as priority pathogens by NIAID and CDC due to their biodefense implications.
Conventional and molecular vaccines for HFRS have progressed to clinical trials.

Conclusions:

Hantaviruses pose a significant global health threat requiring continued vaccine development efforts.
Vaccines are crucial for mitigating the impact of HFRS and HPS, especially in the context of biodefense.